Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 36 for “"Heart--Hypertrophy"”.

  1. Mechanistic insights into copper-induced regression of heart hypertrophy.

    … relevant levels reverses cardiac myocyte hypertrophy induced by phenylephrine (PE), and that this effect was VEGF-dependent. Yet, the amount of VEGF in the media was unchanged. However, we observed that Cu caused an increase in the ratio of VEGFR-1:VEGFR-2 as well as an increase in PKG-1 …

    louisville Repository record for Mechanistic insights into copper-induced regression of heart hypertrophy. (opens in a new tab)

  2. Monocrotaline toxicity and pulmonary arteries

    … develop pulmonary hypertension and right heart hypertrophy in the weeks following administration of the chemical. Lung weight increases and right heart hypertrophy correlate with increased pulmonary artery pressure. Rats which consumed monocrotaline drinking water (20 mg/l) for only 4 days …

    arizona-thes Repository record for Monocrotaline toxicity and pulmonary arteries (opens in a new tab)

  3. Effects Of Dimethylarginine Dimethylaminohydrolase 1 And Adenosine Monophosphate-Activated Protein Kinase Alpha 2 Gene Deletion On Pulmonary Hypertension In Mice

    … mechanism of the development of PAH and right heart hypertrophy/failure. The dissertation has been divided into 2 chapters. The first chapter is determining effect of DDAH1 gene deletion on hypoxia+SU5416-induced pulmonary arterial hypertension and the second chapter is determining effect of …

    umn Repository record for Effects Of Dimethylarginine Dimethylaminohydrolase 1 And Adenosine Monophosphate-Activated Protein Kinase Alpha 2 Gene Deletion On Pulmonary Hypertension In Mice (opens in a new tab)

  4. Myocardial oxidative stress changes during compensated rig t heart failure in rats

    14-34% of heart failure cases are due to an impairment of the right ventricular function and nothing is known about oxidative stress changes in this condition. In order to address this problem, oxidative stress changes were examined in the right ventricle of rats administered monocrotaline (50 …

    manitoba Repository record for Myocardial oxidative stress changes during compensated rig t heart failure in rats (opens in a new tab)

  5. Analysis of the expression regulation of the human atrial myosin light chain 1 upon hypertrophic stimulation

    … in the ventricle of the normal adult human heart. However, ALC-1 is reexpressed in the hypertrophied ventricle of patients with different cardiac diseases. Several in vitro studies as well as transgenic animal models have shown that ALC-1 overexpression leads to an increased cardiac …

    fu-berlin Repository record for Analysis of the expression regulation of the human atrial myosin light chain 1 upon hypertrophic stimulation (opens in a new tab)

  6. TOXICOLOGY OF THE PULMONARY ENDOTHELIUM

    … by the pulmonary endothelium, and right heart hypertrophy. Preceeding the hypertrophy is a doubling of the mass of the lung and right ventricle. The change in mass of the lung preceeds that of the right ventricle. The increases in both organs is characterized by elevated RNA but not DNA. …

    arizona-thes Repository record for TOXICOLOGY OF THE PULMONARY ENDOTHELIUM (opens in a new tab)

  7. MOLECULAR MECHANISMS REGULATING COPPER BALANCE IN HUMAN CELLS

    … Loss of copper homeostasis is associated with heart hypertrophy, liver failure, neuronal de-myelination and other pathologies. The copper-transporting ATPases ATP7A and ATP7B maintain cellular copper homeostasis. In response to copper elevation, they traffic from the trans-Golgi network (TGN) …

    jhu Repository record for MOLECULAR MECHANISMS REGULATING COPPER BALANCE IN HUMAN CELLS (opens in a new tab)

  8. The cellular and molecular mechanisms of oxidant-induced cardiomyocyte hypertrophy

    Cardiac hypertrophy is a common consequence of many cardiovascular diseases. It is often a transition to heart failure. Although oxidants have been indicated to mediate heart failure, whether they induce hypertrophy and how they are able to induce hypertrophy are still unknown. The objective of …

    arizona-thes Repository record for The cellular and molecular mechanisms of oxidant-induced cardiomyocyte hypertrophy (opens in a new tab)

  9. Ang II-Induced Cardiac Remodeling: Role of PI3-Kinase-Dependent Autophagy

    Heart failure (HF) is a pathological state indicating insufficient blood supply to the peripheral tissues from the heart. The pathophysiology of HF is multifactorial like cardiac remodeling including cardiac hypertrophy, perivascular fibrosis and apoptosis to compensate for the heart’s inability to …

    ndsu Repository record for Ang II-Induced Cardiac Remodeling: Role of PI3-Kinase-Dependent Autophagy (opens in a new tab)

  10. Calcineurin bei humaner Herzhypertrophie

    Calcineurin bei humaner Herzhypertrophie

    wurz-thes Repository record for Calcineurin bei humaner Herzhypertrophie (opens in a new tab)

  11. Σχεδιασμός, σύνθεση και αποτίμηση της βιολογικής δράσης νέων ετεροκυκλικών ενώσεων που επάγουν τη δράση της διαλυτής γουανυλικής κυκλάσης

    … leading to hypertension, inflammation, heart hypertrophy and heart failure. In addition, this axis maintains homeostasis in other systems and its dysregulation can lead to e.g. fibrosis in multiple organs or altered metabolic (adipose) function. During the last decades, two classes of …

    greece Repository record for Σχεδιασμός, σύνθεση και αποτίμηση της βιολογικής δράσης νέων ετεροκυκλικών ενώσεων που επάγουν τη δράση της διαλυτής γουανυλικής κυκλάσης (opens in a new tab)

  12. Sarcomere positive and negative hypertrophic cardiomyopathy – two distinct pathophysiological entities?

    … characterised by unexplained left ventricular hypertrophy and significant clinical heterogeneity. In approximately 40% of patients, it is caused by pathogenic sarcomeric gene variants (Sarc+ HCM) which are associated with a greater risk of ventricular arrhythmia, sudden cardiac death and heart …

    oxford Restricted access

  13. PHARMACOLOGICAL ASPECTS OF CARDIAC HYPERTROPHY

    … been implicated in the regulation of cardiac hypertrophy. The serial injection of a catecholamine (epinephrine, norepinephrine or isoproterenol) will increase cardiac muscle mass. In a canine model of left ventricular hypertrophy secondary to aortic coarctation, the endogen

    arizona-thes Repository record for PHARMACOLOGICAL ASPECTS OF CARDIAC HYPERTROPHY (opens in a new tab)

  14. ESTUDIO DE LA RUTA CELULAR JAK2/STAT3 COMO POTENCIAL INHIBIDOR EN EL MODELO DE FIBROSIS PULMONAR

    … reversing vascular remodeling and right heart hypertrophy. Masson trichrome stain revealed a reduction of the collagen deposits. Ashcroft score, used to determine the severity of pulmonary fibrosis, was measured and diminished significantly in the CuI treated group. The results showed a …

    upv Repository record for ESTUDIO DE LA RUTA CELULAR JAK2/STAT3 COMO POTENCIAL INHIBIDOR EN EL MODELO DE FIBROSIS PULMONAR (opens in a new tab)

  15. The expression and function of stretch-activated 2P-4TMD K⁺ channels in the heart.

    … Acid-stimulated K+ channel; KCNK4) in human heart; the localization of TREK-1 and variants of TREK-2 on the membrane and in cytoplasmic areas of human cardiomyocyte; the notably high-level expression of TREK-1 in diseased human heart; the reverse expression of variant A and C of TREK-2 in …

    adelaide Repository record for The expression and function of stretch-activated 2P-4TMD K⁺ channels in the heart. (opens in a new tab)

  16. Ion channel determinants of cardiac hypertrophy and cardiomyopathy

    … in the progression of pressure-overload cardiac hypertrophy. Results show that the absence of TRPV1 in vivo is protective against cardiac hypertrophy under conditions of pressure overload (Chapter 2); however, in the absence of CRACM1 the pathology is exacerbated (Chapter 3). Further, mice …

    hawaii Repository record for Ion channel determinants of cardiac hypertrophy and cardiomyopathy (opens in a new tab)

  17. Development of finite element modeling framework to investigate cardiac hypertrophy in heart diseases

    Heart is a prime organ in the human body, and continuously adapting and evolving through growth and remodeling processes to maintain a balance between the demand and supply of blood and oxygen during physiological/developmental (i.e., from birth to adult) and pathological (i.e., various heart …

    msu Repository record for Development of finite element modeling framework to investigate cardiac hypertrophy in heart diseases (opens in a new tab)

  18. REGULATION OF MYOCARDIAL HYPERTROPHY BY EPINEPHRINE (HEART)

    … propranolol, blocked the usual myocardial hypertrophy that occurs in response to hemodynamic overload. These studies strongly implicate β-adrenoceptors in the regulation of myocardial mass. Theoretically, a circulating myocardial trophic hormone should result in biventricular hypertrophy. …

    arizona-thes Repository record for REGULATION OF MYOCARDIAL HYPERTROPHY BY EPINEPHRINE (HEART) (opens in a new tab)

  19. The role and mechanisms of hexokinase-2-mediated protection against cardiac cell death and disease

    … cardiac HK2 overexpression limits cardiomyocyte hypertrophy and cell death in response to chronic isoproterenol administration in vivo. Results from these studies demonstrate that HK2 limits ROS accumulation during cardiac hypertrophy, and that this attenuation of ROS is mediated via the …

    missouri Repository record for The role and mechanisms of hexokinase-2-mediated protection against cardiac cell death and disease (opens in a new tab)

Page 1 of 2